Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 7, 1997, Pages 878-879

  Ducart, Anne R ^a   Collard, Edith L ^a   Osselaer, Jean C ^a   Broka, Serge M ^a   Eucher, Philippe M ^a   Joucken, Kurt L ^a  

^a University Clinics   (Belgium)

Author keywords

Antiphospholipid syndrome; Cardiopulmonary bypass

Indexed keywords

HEPARIN; LUPUS ANTICOAGULANT;

ADULT; ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030731430     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90125-7     Document Type: Article

References (3)

1. Lockshin MD: Answers to the antiphospholipid antibody syndrome. N Engl J Med 332:1025-1027, 1995
2. Kelly JP, Thomas L, Moulder PV, Webb WR: Coronary bypass surgery in patients with circulating lupus anticoagulant. Ann Thorac Surg 40:261-263, 1985
3. Bull BS, Huse WM, Brauer FS, Korpman RA: Heparin therapy during extracorporeal circulation. J. Thorac Cardiovasc Surg 69:685-689, 1975